Dolasetron Mesylate
CAS 115956-13-3 4 FDA-DMF suppliersSmall Molecule
Overview
Dolasetron Mesylate is a serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting caused by cancer chemotherapy and surgery. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
API suppliers (1)
Suppliers of Dolasetron Mesylate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- ROLABO OUTSOURCING SL
Therapeutic areas
GastroenterologyOncologyAnesthesiology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.